IGF2/H19 hypomethylation is tissue, cell, and CpG site dependent and not correlated with body asymmetry in adolescents with Silver-Russell syndrome

Wollmann HA, Kirchner T, Enders H, Preece MA, Ranke MB: Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr. 1995, 154: 958-968. 10.1007/BF01958638.

Binder G, Begemann M, Eggermann T, Kannenberg K: Silver-Russell syndrome. Best Pract Res Clin Endocrinol Metab. 2011, 25: 153-160. 10.1016/j.beem.2010.06.005.

Wakeling EL: Silver-Russell syndrome. Arch Dis Child. 2011, 96: 1156-1161. 10.1136/adc.2010.190165.

Rizzo V, Traggiai C, Stanhope R: Growth hormone treatment does not alter lower limb asymmetry in children with Russell-Silver syndrome. Horm Res. 2001, 56: 114-116. 10.1159/000048102.

Toumba M, Albanese A, Azcona C, Stanhope R: Effect of long-term growth hormone treatment on final height of children with Russell-Silver syndrome. Horm Res Paediatr. 2010, 74: 212-217. 10.1159/000295924.

Binder G, Seidel AK, Weber K, Haase M, Wollmann HA, Eggermann T: IGF-II serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the IGF2 locus. J Clin Endocrinol Metab. 2006, 91: 4709-4712. 10.1210/jc.2006-1127.

Binder G, Seidel AK, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Eggermann T, Ranke MB: The endocrine phenotype in Silver-Russell syndrome is defined by the underlying epigenetic alteration. J Clin Endocrinol Metab. 2008, 93: 1402-1407. 10.1210/jc.2007-1897.

Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, Danton F, Thibaud N, Le Merrer M, Burglen L, Bertrand AM, Netchine I, Le Bouc Y: Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet. 2005, 37: 1003-1007. 10.1038/ng1629.

Netchine I, Rossignol S, Dufourg MN, Azzi S, Rousseau A, Perin L, Houang M, Steunou V, Esteva B, Thibaud N, Demay MC, Danton F, Petriczko E, Bertrand AM, Heinrichs C, Carel JC, Loeuille GA, Pinto G, Jacquemont ML, Gicquel C, Cabrol S, Le Bouc Y: 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab. 2007, 92: 3148-3154. 10.1210/jc.2007-0354.

Bartholdi D, Krajewska-Walasek M, Ounap K, Gaspar H, Chrzanowska KH, Ilyana H, Kayserili H, Lurie IW, Schinzel A, Baumer A: Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes. J Med Genet. 2009, 46: 192-197.

Bruce S, Hannula-Jouppi K, Peltonen J, Kere J, Lipsanen-Nyman M: Clinically distinct epigenetic subgroups in Silver-Russell syndrome: The degree of H19 hypomethylation associates with phenotype severity and genital and skeletal anomalies. J Clin Endocrin Metab. 2009, 94: 579-587. 10.1210/jc.2008-1805.

Azzi S, Rossignol S, Steunou V, Sas T, Thibaud N, Danton F, Le Jule M, Heinrichs C, Cabrol S, Gicquel C, Le Bouc Y, Netchine I: Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci. Hum Mol Genet. 2009, 18: 4724-4733. 10.1093/hmg/ddp435.

Begemann M, Spengler S, Kanber D, Haake A, Baudis M, Leisten I, Binder G, Markus S, Rupprecht T, Segerer H, Fricke-Otto S, Mühlenberg R, Siebert R, Buiting K, Eggermann T: Silver-Russell patients showing a broad range of ICR1 and ICR2 hypomethylation in different tissues. Clin Genet. 2011, 80: 83-88. 10.1111/j.1399-0004.2010.01514.x.

Kotzot D, Schmitt S, Bernasconi F, Robinson WP, Lurie IW, Ilyina H, Méhes K, Hamel BC, Otten BJ, Hergersberg M, Werder E, Schoenle E, Schinzel A: Uniparental disomy 7 in Silver-Russell syndrome and primordial growth retardation. Hum Mol Genet. 1995, 4: 583-587. 10.1093/hmg/4.4.583.

Ferguson-Smith AC, Cattanach BM, Barton SC, Beechey CV, Surani MA: Embryological and molecular investigations of parental imprinting on mouse chromosome 7. Nature. 1991, 351: 667-670. 10.1038/351667a0.

Li E, Beard C, Jaenisch : Role for DNA methylation in genomic imprinting. Nature. 1993, 366: 362-365. 10.1038/366362a0.

DeChiara TM, Efstratiadis A, Robertson EJ: A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990, 345: 78-80. 10.1038/345078a0.

Frost JM, Moore GE: The importance of imprinting in the human placenta. PLoS Genet. 2010, 6: e1001015-10.1371/journal.pgen.1001015.

Pachnis V, Brannan CI, Tilghman SM: The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J. 1988, 7: 673-681.

Brannan CI, Dees EC, Ingram RS, Tilghman SM: The product of the H19 gene may function as an RNA. Mol Cell Biol. 1990, 10: 28-36.

Bartolomei MS, Zemel S, Tilghman SM: Parental imprinting of the mouse H19 gene. Nature. 1991, 351: 153-155. 10.1038/351153a0.

Bell AC, Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature. 2000, 405: 482-485. 10.1038/35013100.

Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM: CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature. 2000, 405: 486-489. 10.1038/35013106.

Szabó P, Tang SH, Rentsendorj A, Pfeifer GP, Mann JR: Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function. Curr Biol. 2000, 10: 607-610. 10.1016/S0960-9822(00)00489-9.

Weksberg R, Shen DR, Fei YL, Song QL, Squire J: Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet. 1993, 5: 143-150. 10.1038/ng1093-143.

Reik W, Brown KW, Schneid H, Le Bouc Y, Bickmore W, Maher ER: Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain. Hum Mol Genet. 1995, 4: 2379-2385. 10.1093/hmg/4.12.2379.

Gaston V, Le Bouc Y, Soupre V, Burglen L, Donadieu J, Oro H, Audry G, Vazquez MP, Gicquel C: Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2001, 9: 409-418. 10.1038/sj.ejhg.5200649.

Yamazawa K, Kagami M, Nagai T, Kondoh T, Onigata K, Maeyama K, Hasegawa T, Hasegawa Y, Yamazaki T, Mizuno S, Miyoshi Y, Miyagawa S, Horikawa R, Matsuoka K, Ogata T: Molecular and clinical findings and their correlations in Silver-Russell syndrome: implications for a positive role of IGF2 in growth determination and differential imprinting regulation of the IGF2-H19 domain in bodies and placentas. J Mol Med (Berl). 2008, 86: 1171-1181. 10.1007/s00109-008-0377-4.

Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers HH: The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat Genet. 1993, 5: 74-78. 10.1038/ng0993-74.

Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P: An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977–1981). Acta Paediatr Scand. 1991, 80: 756-762. 10.1111/j.1651-2227.1991.tb11945.x.

Kannenberg K, Urban C, Binder G: Increased incidence of aberrant DNA methylation within diverse imprinted gene loci outside of IGF2/H19 in Silver-Russell syndrome. Clin Genet. 2012, 81: 366-377. 10.1111/j.1399-0004.2012.01844.x.

Koch CM, Suschek CV, Qiong L, Bork S, Goergens M, Joussen S, Pallua N, Ho AD, Zenke M, Wagner W: Specific Age-associated DNA methylation changes in human dermal fibroblasts. PLoS One. 2011, 6: e16679-10.1371/journal.pone.0016679.

Koch CM, Joussen S, Schellenberg A, Qiong L, Zenke M, Wagner W: Monitoring of cellular senescence by DNA-methylation at specific CpG sites. Aging Cell. 2012, 11: 366-369. 10.1111/j.1474-9726.2011.00784.x.

Constância M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W: Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature. 2002, 417: 945-948. 10.1038/nature00819.

Kurukuti S, Tiwari VK, Tavoosidana G, Pugacheva E, Murrell A, Zhao Z, Lobanenkov V, Reik W, Ohlsson R: CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. Proc Natl Acad Sci USA. 2006, 103: 10684-10689. 10.1073/pnas.0600326103.

Ulaner GA, Yang Y, Hu JF, Li T, Vu TH, Hoffman AR: CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues. Endocrinology. 2003, 144: 4420-4426. 10.1210/en.2003-0681.

Montenegro LR, Leal AC, Coutinho DC, Valassi HP, Nishi MY, Arnhold IJ, Mendonca BB, Jorge AA: Post-receptor IGF-1 insensitivity restricted to the MAPK pathway in a silver-Russell syndrome patient with hypomethylation at the imprinting control region on chromosome 11. Eur J Endocrinol. 2012, 166: 543-550. 10.1530/EJE-11-0964.

Nygren AO, Ameziane N, Duarte HM, Vijzelaar RNCP, Waisfisz Q, Hess CJ, Schouten JP, Errami A: Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 2005, 33: e128-10.1093/nar/gni127.

Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30: e57-10.1093/nar/gnf056.

Sellner LN, Taylor GR: MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat. 2004, 23: 413-419. 10.1002/humu.20035.

Cory AH, Owen TC, Barltrop JA, Cory JG: Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991, 3: 207-212.